{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T02:38:08Z","timestamp":1787020688196,"version":"build-2736575974"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,5,18]],"date-time":"2022-05-18T00:00:00Z","timestamp":1652832000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,5,18]],"date-time":"2022-05-18T00:00:00Z","timestamp":1652832000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100014718","name":"Innovative Research Group Project of the National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81672987"],"award-info":[{"award-number":["81672987"]}],"id":[{"id":"10.13039\/100014718","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014718","name":"Innovative Research Group Project of the National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82073329"],"award-info":[{"award-number":["82073329"]}],"id":[{"id":"10.13039\/100014718","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003453","name":"Natural Science Foundation of Guangdong Province","doi-asserted-by":"publisher","award":["2020A1515011286"],"award-info":[{"award-number":["2020A1515011286"]}],"id":[{"id":"10.13039\/501100003453","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Radiat Oncol"],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>High dose chemoradiotherapy offers a curative chance for patients with rectal cancer that are unfit or unwilling to undergo surgical resection, yet its long-term survival and functional outcomes have been rarely investigated.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Patients with non-metastatic rectal adenocarcinoma who received pelvic radiation for curative intent from April 2006 to July 2017 were retrospectively investigated. Survival rates were analyzed using the Kaplan\u2013Meier method. Quality of life and functional outcomes were evaluated using the EORTC quality of life questionnaire.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>A total of 57 patients were included, with a median age of 59.0 (range, 29\u201384) years. The numbers of patients who were diagnosed as stage I, II and III were 5 (8.8%), 16 (28.1%) and 36 (63.2%), respectively. 53 (93.0%) patients had tumor located within 5\u00a0cm from the anal verge. All patients received fluorouracil-based concurrent chemoradiotherapy with a median radiation dose of 80 (range, 60\u201386) Gy. All kinds of grade 3\u20134 adverse events occurred in 18 (31.6%) patients. 42 (73.7%) patients achieved a clinical complete response after chemoradiotherapy. After a median follow-up of 43.5 (range 14.9\u2013163.2) months, 12 (21.1%) patients had local progression and 11 (19.3%) developed distant metastasis. The 3-year local recurrence-free survival and distant metastasis-free survival were 77.3% (95% CI, 65.7\u201388.8%) and 79.2% (95% CI, 68.2\u201390.2%), while the 3-year progression-free survival, cancer-specific survival, overall survival were 61.9% (95% CI, 48.8\u201375.0%), 93.1% (95% CI, 85.8\u2013100.0%) and 91.4% (95% CI, 83.6\u201399.2%), respectively. For patients who had tumor located within 3\u00a0cm from the anal verge, the sphincter preservation rate was 85.3% at last follow-up. Long-term adverse events mainly were anal blood loss. 21 patients completed the quality-of-life questionnaire and had a score of the global health status of 78.57\u2009\u00b1\u200917.59. Of them, 95.2% reported no urinary incontinence and 85.7% reported no fecal incontinence.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>High dose chemoradiation demonstrated promising survival outcomes with acceptable short-term and long-term side effects, and satisfying long-term functional outcomes and quality of life. It could be considered as a non-invasive alternative for rectal cancer patients who refuse surgery.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13014-022-02066-7","type":"journal-article","created":{"date-parts":[[2022,5,18]],"date-time":"2022-05-18T10:03:11Z","timestamp":1652868191000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["High dose chemoradiotherapy increases chance of organ preservation with satisfactory functional outcome for rectal cancer"],"prefix":"10.1186","volume":"17","author":[{"given":"Qiao-Xuan","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei-Wei","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheng-Jing","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhi-Fan","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pei-Qiang","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhen-Hai","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gong","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pei-Rong","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhi-Zhong","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-Jun","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6429-5376","authenticated-orcid":false,"given":"Yuan-Hong","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,5,18]]},"reference":[{"issue":"7","key":"2066_CR1","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1016\/j.ejso.2005.05.004","volume":"31","author":"MG Guren","year":"2005","unstructured":"Guren MG, Eriksen MT, Wiig JN, Carlsen E, Nesbakken A, Sigurdsson HK, Wibe A, Tveit KM. Quality of life and functional outcome following anterior or abdominoperineal resection for rectal cancer. Eur J Surg Oncol. 2005;31(7):735\u201342.","journal-title":"Eur J Surg Oncol"},{"issue":"2","key":"2066_CR2","first-page":"Cd006041","volume":"2013","author":"L De Caluw\u00e9","year":"2013","unstructured":"De Caluw\u00e9 L, Van Nieuwenhove Y, Ceelen WP. Preoperative chemoradiation versus radiation alone for stage II and III resectable rectal cancer. Cochrane Database Syst Rev. 2013;2013(2):Cd006041.","journal-title":"Cochrane Database Syst Rev"},{"issue":"3","key":"2066_CR3","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1097\/SLA.0b013e3181485617","volume":"246","author":"VW Fazio","year":"2007","unstructured":"Fazio VW, Zutshi M, Remzi FH, Parc Y, Ruppert R, F\u00fcrst A, Celebrezze J Jr, Galanduik S, Orangio G, Hyman N, et al. A randomized multicenter trial to compare long-term functional outcome, quality of life, and complications of surgical procedures for low rectal cancers. Ann Surg. 2007;246(3):481\u20138 (discussion 488\u2013490).","journal-title":"Ann Surg"},{"issue":"1","key":"2066_CR4","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1002\/cac2.12003","volume":"40","author":"J Huang","year":"2020","unstructured":"Huang J, Liu J, Fang J, Zeng Z, Wei B, Chen T, Wei H. Identification of the surgical indication line for the Denonvilliers\u2019 fascia and its anatomy in patients with rectal cancer. Cancer Commun (Lond). 2020;40(1):25\u201331.","journal-title":"Cancer Commun (Lond)"},{"issue":"1","key":"2066_CR5","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1186\/s40880-018-0294-z","volume":"38","author":"X Yu","year":"2018","unstructured":"Yu X, Wang QX, Xiao WW, Chang H, Zeng ZF, Lu ZH, Wu XJ, Chen G, Pan ZZ, Wan DS, et al. Neoadjuvant oxaliplatin and capecitabine combined with bevacizumab plus radiotherapy for locally advanced rectal cancer: results of a single-institute phase II study. Cancer Commun (Lond). 2018;38(1):24.","journal-title":"Cancer Commun (Lond)"},{"key":"2066_CR6","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1146\/annurev-med-062915-021419","volume":"68","author":"GL Beets","year":"2017","unstructured":"Beets GL, Figueiredo NF, Beets-Tan RG. Management of rectal cancer without radical resection. Annu Rev Med. 2017;68:169\u201382.","journal-title":"Annu Rev Med"},{"issue":"4","key":"2066_CR7","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1097\/01.sla.0000141194.27992.32","volume":"240","author":"A Habr-Gama","year":"2004","unstructured":"Habr-Gama A, Perez RO, Nadalin W, Sabbaga J, Ribeiro U Jr, Silva e Sousa AH Jr, Campos FG, Kiss DR, Gama-Rodrigues J. Operative versus nonoperative treatment for stage 0 distal rectal cancer following chemoradiation therapy: long-term results. Ann Surg. 2004;240(4):711\u20137 (discussion 717\u2013718).","journal-title":"Ann Surg"},{"issue":"35","key":"2066_CR8","doi-asserted-by":"publisher","first-page":"4633","DOI":"10.1200\/JCO.2011.37.7176","volume":"29","author":"M Maas","year":"2011","unstructured":"Maas M, Beets-Tan RG, Lambregts DM, Lammering G, Nelemans PJ, Engelen SM, van Dam RM, Jansen RL, Sosef M, Leijtens JW, et al. Wait-and-see policy for clinical complete responders after chemoradiation for rectal cancer. J Clin Oncol. 2011;29(35):4633\u201340.","journal-title":"J Clin Oncol"},{"issue":"6","key":"2066_CR9","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1097\/SLA.0b013e3182759f1c","volume":"256","author":"JD Smith","year":"2012","unstructured":"Smith JD, Ruby JA, Goodman KA, Saltz LB, Guillem JG, Weiser MR, Temple LK, Nash GM, Paty PB. Nonoperative management of rectal cancer with complete clinical response after neoadjuvant therapy. Ann Surg. 2012;256(6):965\u201372.","journal-title":"Ann Surg"},{"issue":"7","key":"2066_CR10","doi-asserted-by":"publisher","first-page":"1904","DOI":"10.1245\/s10434-017-5841-3","volume":"24","author":"T Sammour","year":"2017","unstructured":"Sammour T, Price BA, Krause KJ, Chang GJ. Nonoperative management or \u201cwatch and wait\u201d for rectal cancer with complete clinical response after neoadjuvant chemoradiotherapy: a critical appraisal. Ann Surg Oncol. 2017;24(7):1904\u201315.","journal-title":"Ann Surg Oncol"},{"issue":"1","key":"2066_CR11","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.ijrobp.2012.05.017","volume":"85","author":"AL Appelt","year":"2013","unstructured":"Appelt AL, Pl\u00f8en J, Vogelius IR, Bentzen SM, Jakobsen A. Radiation dose-response model for locally advanced rectal cancer after preoperative chemoradiation therapy. Int J Radiat Oncol Biol Phys. 2013;85(1):74\u201380.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"8","key":"2066_CR12","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1016\/S1470-2045(15)00120-5","volume":"16","author":"AL Appelt","year":"2015","unstructured":"Appelt AL, Pl\u00f8en J, Harling H, Jensen FS, Jensen LH, J\u00f8rgensen JC, Lindebjerg J, Rafaelsen SR, Jakobsen A. High-dose chemoradiotherapy and watchful waiting for distal rectal cancer: a prospective observational study. Lancet Oncol. 2015;16(8):919\u201327.","journal-title":"Lancet Oncol"},{"key":"2066_CR13","unstructured":"AJCC Cancer Staging Manual, 7th edn. 2010."},{"issue":"3","key":"2066_CR14","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1016\/S1053-4296(03)00031-6","volume":"13","author":"A Trotti","year":"2003","unstructured":"Trotti A, Colevas A, Setser A, Rusch V, Jaques D, Budach V, Langer C, Murphy B, Cumberlin R, Coleman C. CTCAE v3.0: development of a comprehensive grading system for the adverse effects of cancer treatment. Semin Radiat Oncol. 2003;13(3):176\u201381.","journal-title":"Semin Radiat Oncol"},{"issue":"17","key":"2066_CR15","doi-asserted-by":"publisher","first-page":"3017","DOI":"10.1016\/j.ejca.2009.08.014","volume":"45","author":"RN Whistance","year":"2009","unstructured":"Whistance RN, Conroy T, Chie W, Costantini A, Sezer O, Koller M, Johnson CD, Pilkington SA, Arraras J, Ben-Josef E, et al. Clinical and psychometric validation of the EORTC QLQ-CR29 questionnaire module to assess health-related quality of life in patients with colorectal cancer. Eur J Cancer. 2009;45(17):3017\u201326.","journal-title":"Eur J Cancer"},{"issue":"5","key":"2066_CR16","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1093\/jnci\/85.5.365","volume":"85","author":"NK Aaronson","year":"1993","unstructured":"Aaronson NK, Ahmedzai S, Bergman B, Bullinger M, Cull A, Duez NJ, Filiberti A, Flechtner H, Fleishman SB, de Haes JC, et al. The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst. 1993;85(5):365\u201376.","journal-title":"J Natl Cancer Inst"},{"issue":"1","key":"2066_CR17","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1016\/S0360-3016(02)02879-1","volume":"54","author":"JP Gerard","year":"2002","unstructured":"Gerard JP, Chapet O, Ramaioli A, Romestaing P. Long-term control of T2\u2013T3 rectal adenocarcinoma with radiotherapy alone. Int J Radiat Oncol Biol Phys. 2002;54(1):142\u20139.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"6","key":"2066_CR18","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1016\/S1470-2045(11)70097-3","volume":"12","author":"W van Gijn","year":"2011","unstructured":"van Gijn W, Marijnen CA, Nagtegaal ID, Kranenbarg EM, Putter H, Wiggers T, Rutten HJ, P\u00e5hlman L, Glimelius B, van de Velde CJ. Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer: 12-year follow-up of the multicentre, randomised controlled TME trial. Lancet Oncol. 2011;12(6):575\u201382.","journal-title":"Lancet Oncol"},{"issue":"10139","key":"2066_CR19","doi-asserted-by":"publisher","first-page":"2537","DOI":"10.1016\/S0140-6736(18)31078-X","volume":"391","author":"MJM van der Valk","year":"2018","unstructured":"van der Valk MJM, Hilling DE, Bastiaannet E, Meershoek-Klein Kranenbarg E, Beets GL, Figueiredo NL, Habr-Gama A, Perez RO, Renehan AG, van de Velde CJH. Long-term outcomes of clinical complete responders after neoadjuvant treatment for rectal cancer in the International Watch & Wait Database (IWWD): an international multicentre registry study. Lancet. 2018;391(10139):2537\u201345.","journal-title":"Lancet"},{"issue":"3","key":"2066_CR20","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1016\/j.ijrobp.2019.10.046","volume":"106","author":"E Dizdarevic","year":"2020","unstructured":"Dizdarevic E, Fr\u00f8strup Hansen T, Pl\u00f8en J, Henrik Jensen L, Lindebjerg J, Rafaelsen S, Jakobsen A, Appelt A. Long-term patient-reported outcomes after high-dose chemoradiation therapy for nonsurgical management of distal rectal cancer. Int J Radiat Oncol Biol Phys. 2020;106(3):556\u201363.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"1","key":"2066_CR21","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.radonc.2014.08.035","volume":"113","author":"JP Burbach","year":"2014","unstructured":"Burbach JP, den Harder AM, Intven M, van Vulpen M, Verkooijen HM, Reerink O. Impact of radiotherapy boost on pathological complete response in patients with locally advanced rectal cancer: a systematic review and meta-analysis. Radiother Oncol. 2014;113(1):1\u20139.","journal-title":"Radiother Oncol"},{"issue":"10","key":"2066_CR22","doi-asserted-by":"publisher","first-page":"1032","DOI":"10.1097\/DCR.0000000000000862","volume":"60","author":"BJP Hupkens","year":"2017","unstructured":"Hupkens BJP, Martens MH, Stoot JH, Berbee M, Melenhorst J, Beets-Tan RG, Beets GL, Breukink SO. Quality of life in rectal cancer patients after chemoradiation: watch-and-wait policy versus standard resection\u2014a matched-controlled study. Dis Colon Rectum. 2017;60(10):1032\u201340.","journal-title":"Dis Colon Rectum"},{"issue":"9","key":"2066_CR23","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1016\/j.clon.2007.07.018","volume":"19","author":"A Sun Myint","year":"2007","unstructured":"Sun Myint A, Lee CD, Snee AJ, Perkins K, Jelley FE, Wong H. High dose rate brachytherapy as a boost after preoperative chemoradiotherapy for more advanced rectal tumours: the Clatterbridge experience. Clin Oncol (R Coll Radiol). 2007;19(9):711\u20139.","journal-title":"Clin Oncol (R Coll Radiol)"}],"container-title":["Radiation Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13014-022-02066-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13014-022-02066-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13014-022-02066-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,18]],"date-time":"2022-05-18T10:14:46Z","timestamp":1652868886000},"score":1,"resource":{"primary":{"URL":"https:\/\/ro-journal.biomedcentral.com\/articles\/10.1186\/s13014-022-02066-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5,18]]},"references-count":23,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["2066"],"URL":"https:\/\/doi.org\/10.1186\/s13014-022-02066-7","relation":{},"ISSN":["1748-717X"],"issn-type":[{"value":"1748-717X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,5,18]]},"assertion":[{"value":"7 December 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 May 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 May 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All the procedures were approved by the ethical committee in Sun Yat-sen University Cancer Center (Guangzhou, China). All patients provided written informed consent for the collection and publication of their medical information at the first visit to our center, which was filed in their medical records.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"We declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"98"}}